MERIDIAN DIAGNOSTICS INC
SC 13G/A, 1997-01-24
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: KENT ELECTRONICS CORP, S-8, 1997-01-24
Next: UNUM CORP, 15-15D, 1997-01-24



                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549


                                  SCHEDULE 13G


                    UNDER THE SECURITIES EXCHANGE ACT OF 1934
                               (AMENDMENT NO. 10)*



                           MERIDIAN DIAGNOSTICS, INC.
- --------------------------------------------------------------------------------
                                (NAME OF ISSUER)



                                  Common Stock
- --------------------------------------------------------------------------------
                         (TITLE OF CLASS OF SECURITIES)


                                   589602 10 1
- --------------------------------------------------------------------------------
                                 (CUSIP NUMBER)

Check the following  box if a fee is being paid with this  statement [ ]. (A fee
is not required only if the filing person:  (1) has a previous statement on file
reporting  beneficial  ownership  of more  than  five  percent  of the  class of
securities  described  in Item 1;  and (2) has  filed  no  amendment  subsequent
thereto reporting  beneficial  ownership of five percent or less of such class.)
(See Rule 13d-7.)

*The  remainder of this cover page shall be filled out for a reporting  person's
initial filing on this form with respect to the subject class of securities, and
for any  subsequent  amendment  containing  information  which  would  alter the
disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the  Securities  Exchange  Act of
1934 ("Act") or otherwise  subject to the liabilities of that section of the Act
but  shall be  subject  to all other  provisions  of the Act  (however,  see the
Notes).


                        (Continued on following page(s))

                                Page 1 of 4 Pages


<PAGE>





 CUSIP NO. 589602 10 1             13G                      PAGE  2 OF  4  PAGES



 1      NAME OF REPORTING PERSONS
        S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

           JERRY L. RUYAN
           ###-##-####

- ------- ------------------------------------------------------------------------
 2      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*            (a)   [ ]
           See Item 4                                                (b)   [X]

- ------- ------------------------------------------------------------------------
 3      SEC USE ONLY



- ------- ------------------------------------------------------------------------
 4      CITIZENSHIP OR PLACE OF ORGANIZATION

           United States of America

- ------- ------------------------------------------------------------------------
                        5      SOLE VOTING POWER
       NUMBER OF                  566,188
        SHARES         ------- -------------------------------------------------
     BENEFICIALLY         6      SHARED VOTING POWER                            
       OWNED BY                       0    
         EACH          ------- -------------------------------------------------
       REPORTING           7      SOLE DISPOSITIVE POWER                        
      PERSON WITH                 566,188                                       
                       ------- -------------------------------------------------
                          8      SHARED DISPOSITIVE POWER   
                                   0
- --------------------------------------------------------------------------------
 9      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

             566,188
- ------- ------------------------------------------------------------------------
10      CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*

- ------- ------------------------------------------------------------------------
11      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

              3.9%
- ------- ------------------------------------------------------------------------
12      TYPE OF REPORTING PERSON*

             IN
- ------- ------------------------------------------------------------------------

                      *SEE INSTRUCTIONS BEFORE FILLING OUT!


<PAGE>



                                                        Page 3 of 4 Pages


ITEM    1(a)   Name of Issuer:              Meridian Diagnostics, Inc.

        1(b)   Address of Issuer's Principal Executive Office:

               3471 River Hills Drive
               Cincinnati, Ohio  45244

        2(a)   Name of Persons Filing:             Jerry L. Ruyan

        2(b)   Address of Principal Business Office:

               10260 Alliance Road, Suite 350
               Cincinnati, Ohio  45242

        2(c)   Citizenship:         U.S.A.

        2(d)   Title of Class of Securities:      Common Stock, No Par Value

        2(e)   CUSIP No.:           589602 10 1
               
        3.     If this Statement is Filed Pursuant to Rules 13d-1(b) or
               13d-2(b), check whether the Person Filing is a:   N/A

        4.     Ownership:

               (a)    See Item 9 of cover page.
               (b)    See Item 11 of cover page.
               (c)    See Items 5-8 of cover page.

          This  Amendment  No. 10 to  Schedule  13G is filed  solely by Jerry L.
          Ruyan. The original Schedule 13G and all amendments prior to Amendment
          No. 6 to  Schedule  13G were  filed by Jerry L.  Ruyan and  William J.
          Motto on the same Schedule 13G.

          The shares in Items 5, 7 and 9 include  options  that are  exercisable
          within 60 days into 65,012 shares,  23,265 shares held by Mr. Ruyan as
          trustee of the Ruyan Family  Charitable  Remainder  Unitrust and 4,081
          shares held as custodian for his son.

          William  J.  Motto and  Jerry L.  Ruyan are  parties  to an  agreement
          ("Agreement") with the Company pursuant to which they must offer their
          shares for sale to the Company, and if it declines to purchase, to the
          other at a price  based on current  market  prices,  if either of them
          desires to sell  shares in excess of 1% of the  Company's  outstanding
          Common Stock in any three-month period. Mr. Ruyan does not affirm that
          the  Agreement  operates to make  Messrs.  Motto and Ruyan a group for
          purposes of Section 13(d)(3) of the Securities


<PAGE>



          Exchange Act of 1934. The Agreement previously was filed as an Exhibit
          to  Registration  Statement No.  33-6052.  The First  Amendment to the
          Agreement,  which  removed  Richard  H.  Walter  as  a  party  to  the
          Agreement,  previously  was  filed as an  Exhibit  to the Form 10-K of
          Meridian  Diagnostics,  Inc. for the fiscal year ended  September  30,
          1992.

     5.   Ownership of 5% or less of class:  If this statement is being filed to
          report the fact that as of the date  hereof the  reporting  person has
          ceased  to be the  beneficial  owner of more  than 5% of the  class of
          securities, check the following. |X|

     6.   Ownership of more than 5% on behalf of another person:N/A

     7.   Identification and classification of the subsidiary which acquired the
          security being reported by the parent holding company: N/A

     8.   Identification and classification of members of the group: N/A

     9.   Notice of dissolution of group: N/A

     10.  Certification: N/A



        After  reasonable  inquiry and to the best of my knowledge and belief, I
certify that the information  set forth in this statement is true,  complete and
correct.



Date:  January 23, 1997                             /s/ Jerry L. Ruyan
     -------------------------                     -------------------
                                                      Jerry L. Ruyan



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission